Allergy Testing
Bronchodilator Reversibility Testing
Bronchodilator reversibility testing measures airway response to inhaled medication — key for asthma diagnosis.
What This Test Evaluates
- Airway reversibility (asthma indicator)
- Response to bronchodilator medication
- Distinguishing asthma from COPD
- Fixed vs. reversible airflow obstruction
Who May Need This Test
- Patients with suspected asthma
- Patients with suspected COPD
- Patients with airflow obstruction on spirometry
- Patients with unclear respiratory diagnosis
Preparation Requirements
- Stop short-acting bronchodilators 4–6h before
- Stop long-acting bronchodilators as directed
- Inform of all respiratory medications
- No smoking before test
Procedure
- Baseline spirometry performed
- Administer bronchodilator (salbutamol/albuterol)
- Wait 15–30 minutes
- Repeat spirometry
- Compare pre and post values
Interpretation
- Significant improvement (≥12% and ≥200ml FEV1 increase) suggests asthma
- Minimal improvement suggests fixed obstruction (COPD)
- Reversibility supports asthma diagnosis
- Lack of reversibility does not exclude asthma (may need challenge testing)
Limitations
- May be negative in well-controlled or mild asthma
- Requires patient effort for spirometry
- Cannot distinguish all phenotypes
- May need bronchoprovocation testing if negative but suspicion remains
Follow-Up
- Guide asthma vs. COPD diagnosis
- Determine treatment approach
- Assess response to bronchodilator therapy
- Further testing if results inconclusive
Related Pages
Ready to get answers?
Book a specialist consultation to discuss your symptoms and treatment options.
Medical disclaimer: This page is for educational purposes and does not constitute medical advice. Individual diagnosis and treatment require consultation with a qualified healthcare professional. If you are experiencing a medical emergency, seek immediate care.